U.S. and Canada Peritoneal Dialysis Catheters Market Size, Share, and Trends 2026 to 2035

Payal Rabde, a Healthcare Industry Expert, highlights that the U.S. & Canada peritoneal dialysis catheters market has reached USD 179.42 million in 2026 and is on track to reach USD 324.36 million by 2035, advancing at a CAGR of 6.8%. Key U.S. & Canada peritoneal dialysis catheters market companies shaping the market include Medtronic, Baxter International (Vantive), Fresenius Medical Care, while major growth segments span catheter type, insertion, end-user.

Last Updated : 20 Nov 2026  |  Report Code : 8993  |  Category : Healthcare   |  Format : PDF / PPT / Excel

1. Market Overview & Sizing

1.1 U.S. & Canada Peritoneal Dialysis Catheters Market: Definition and Scope

1.1.1 Market Definition and Scope of Study

1.1.2 Inclusions and Exclusions

1.1.3 Currency, Units and Base Year

1.2 U.S. & Canada Peritoneal Dialysis Catheters Market Taxonomy

1.2.1 By Catheter Type

1.2.2 By Insertion

1.2.3 By End User

1.3 U.S. & Canada Peritoneal Dialysis Catheters Market Size and Forecast, 2025-2035

1.3.1 Market Value (USD) and Annual Growth

1.3.2 Historical Market Analysis

1.3.3 Market Growth Analysis and CAGR 2026-2035

1.4 U.S. & Canada Peritoneal Dialysis Catheters Market Penetration and Maturity Analysis

1.5 Addressable Market Analysis (TAM, SAM, SOM) for U.S. & Canada Peritoneal Dialysis Catheters

1.6 U.S. & Canada Peritoneal Dialysis Catheters Market Value Chain Analysis

1.7 U.S. & Canada Peritoneal Dialysis Catheters Market Ecosystem Analysis

2. Market Dynamics & Opportunities

2.1 U.S. & Canada Peritoneal Dialysis Catheters Market Dynamics Overview

2.2 Growth Drivers

2.2.1 Kidney failure rises

2.2.2 Home dialysis incentives

2.2.3 Patient preference for home care

2.2.4 Lower cost than in-centre HD

2.3 Market Drivers - Impact & CAGR Contribution (2026-2035)

2.4 Market Restraints

2.4.1 Catheter infections and failure

2.4.2 Limited surgeon training

2.4.3 Low PD awareness

2.4.4 Reimbursement for placement

2.5 Market Restraints - Impact & Negative CAGR Contribution (2026-2035)

2.6 Market Challenges

2.7 Emerging Opportunities

2.7.1 Urgent-start PD

2.7.2 Percutaneous placement

2.7.3 Canada growth

2.7.4 Home dialysis models

2.8 Key Trends in the U.S. & Canada Peritoneal Dialysis Catheters Market

2.8.1 Home dialysis policy incentives

2.8.2 Urgent-start PD

2.8.3 Percutaneous placement

2.8.4 Infection prevention

2.8.5 New PD cyclers

2.8.6 Canada high PD use

2.9 Unmet Needs, White Space and Gap Analysis

2.10 Industry Evolution and Transformation of the U.S. & Canada Peritoneal Dialysis Catheters Market

3. Segmentation & Forecast

3.1 U.S. & Canada Peritoneal Dialysis Catheters Market, by Catheter Type (Share %, 2025-2035)

3.1.1 Swan-Neck Catheters: Market Share and CAGR

3.1.2 Straight Tenckhoff Catheters: Market Share and CAGR

3.1.3 Coiled & Others: Market Share and CAGR

3.2 U.S. & Canada Peritoneal Dialysis Catheters Market, by Insertion (Share %, 2025-2035)

3.2.1 Laparoscopic: Market Share and CAGR

3.2.2 Percutaneous: Market Share and CAGR

3.2.3 Open Surgical: Market Share and CAGR

3.3 U.S. & Canada Peritoneal Dialysis Catheters Market, by End User (Share %, 2025-2035)

3.3.1 Hospitals: Market Share and CAGR

3.3.2 Dialysis Centres: Market Share and CAGR

3.3.3 Ambulatory Surgical Centres: Market Share and CAGR

3.4 Segment Attractiveness and Growth Comparison

4. Regional & Country Intelligence

4.1 U.S. Peritoneal Dialysis Catheters Market

4.1.1 Market Size and Forecast, 2025-2035

4.1.2 Market Share by Catheter Type

4.1.3 Demand Drivers, Regulation and Local Competition

4.2 Canada Peritoneal Dialysis Catheters Market

4.2.1 Market Size and Forecast, 2025-2035

4.2.2 Market Share by Catheter Type

4.2.3 Demand Drivers, Regulation and Local Competition

4.3 Country Attractiveness and Market Entry Assessment

5. Competitive & Company Intelligence

5.1 U.S. & Canada Peritoneal Dialysis Catheters Market Competitive Landscape Overview

5.2 Market Share by Company, 2025

5.3 Company Ranking and Competitive Indexing

5.4 Precedence Research Companies Quadrant

5.5 Competitive Benchmarking

5.5.1 Product Portfolio Benchmarking

5.5.2 Geographic Presence Benchmarking

5.5.3 Technology and Innovation Benchmarking

5.6 Strategic Group Mapping

5.7 Barriers to Entry and New Entrant Analysis

5.8 Mergers, Acquisitions and Strategic Partnerships

5.9 Recent Developments in the U.S. & Canada Peritoneal Dialysis Catheters Market

6. Pricing Intelligence

6.1 U.S. & Canada Peritoneal Dialysis Catheters Market Pricing Overview

6.1.1 Average selling price by product and procedure type

6.1.2 Hospital contract and group purchasing organisation (GPO) pricing

6.1.3 Reimbursement-linked pricing and DRG impact

6.1.4 Premium vs. value-tier device pricing

6.2 Pricing by Catheter Type

6.3 Pricing by Country

6.4 Historical Price Trend and Price Forecast, 2025-2035

6.5 Cost Structure, Margin and Price Sensitivity Analysis

6.6 Competitor Pricing Benchmarking

7. Buyer & Customer Intelligence

7.1 U.S. & Canada Peritoneal Dialysis Catheters Market Buyer Landscape

7.1.1 Hospitals and integrated delivery networks

7.1.2 Ambulatory surgical centres and specialty clinics

7.1.3 Group purchasing organisations and tender bodies

7.1.4 Clinician (KOL) influence on device selection

7.2 Buyer Segmentation and Purchasing Patterns

7.3 Buying Criteria and Decision-Making Process

7.4 Customer Pain Points and Unmet Needs

7.5 Customer Retention, Switching and Loyalty Analysis

8. Buying, Selling & Procurement

8.1 Procurement Strategies and Supplier Selection Criteria

8.2 Sales Channel Analysis: Direct vs. Indirect

8.3 Distributor and Dealer Network Analysis

8.4 Key Account and Contract Analysis

8.5 Cross-Selling and Upselling Opportunities

9. Supply Chain & Manufacturing

9.1 U.S. & Canada Peritoneal Dialysis Catheters Market Supply Chain Mapping

9.1.1 Raw materials and component suppliers

9.1.2 Contract manufacturers and sterilisation providers

9.1.3 Distribution through medical device distributors

9.1.4 Hospital inventory and consignment models

9.2 Supplier Landscape and Concentration

9.3 Manufacturing Footprint and Capacity Analysis

9.4 Supply Chain Risk and Resilience

10. Trade & Distribution

10.1 Import and Export Analysis

10.2 Major Exporting and Importing Countries

10.3 Tariffs, Duties and Trade Regulations

10.4 Distribution Channel Share and E-commerce Analysis

11. Technology & Innovation

11.1 U.S. & Canada Peritoneal Dialysis Catheters Market Technology Landscape

11.1.1 Next-generation device design and materials

11.1.2 Imaging, navigation and digital integration

11.1.3 AI-enabled clinical decision support

11.1.4 Patent landscape and freedom-to-operate

11.2 Innovation Pipeline and R&D Investment Analysis

11.3 Technology Adoption and Readiness Analysis

11.4 Future Technology Roadmap

12. Regulatory & Risk

12.1 U.S. & Canada Peritoneal Dialysis Catheters Market Regulatory Landscape

12.1.1 FDA 510(k), De Novo and PMA pathways

12.1.2 EU MDR certification and notified body capacity

12.1.3 Clinical evidence and post-market surveillance requirements

12.1.4 Recalls, safety notices and quality system risks

12.2 Regulatory Risk and Compliance Cost Analysis

12.3 Political, Economic and Supply Risk Assessment

13. Investment & Financial

13.1 U.S. & Canada Peritoneal Dialysis Catheters Market Investment Landscape

13.2 Funding, Venture Capital and Private Equity Activity

13.3 M&A Landscape and Valuation Benchmarking

13.4 Revenue Pool and Profit Pool Analysis

13.5 Investment Opportunity Mapping

14. GTM & Commercial Strategy

14.1 Market Entry and Expansion Strategy

14.2 Go-to-Market Strategy by Customer Segment

14.3 Partnership and Commercialisation Opportunities

14.4 Opportunity Prioritisation Matrix

15. Advanced Forecasting & Scenarios

15.1 Scenario-Based Forecast for the U.S. & Canada Peritoneal Dialysis Catheters Market (Base, Optimistic, Pessimistic)

15.2 Sensitivity Analysis of Key Assumptions

15.3 Demand-Supply Gap Forecast

15.4 Market Risk and Uncertainty Assessment

15.5 Long-Term Market Outlook to 2035

16. Industry-Specific Intelligence: Medical Device

16.1 Procedure volume analysis

16.2 Patient pool and disease prevalence

16.3 Clinical evidence and guideline adoption

16.4 Reimbursement landscape by country

16.5 Installed base and replacement cycle analysis

16.6 Hospital adoption and utilisation analysis

17. Company Profiles & Benchmarking

17.1 Medtronic

17.1.1 Company Overview

17.1.2 U.S. & Canada Peritoneal Dialysis Catheters Product Portfolio

17.1.3 Financial Performance and Market Share

17.1.4 Recent Developments and Strategy

17.1.5 SWOT Analysis

17.2 Baxter International (Vantive)

17.2.1 Company Overview

17.2.2 U.S. & Canada Peritoneal Dialysis Catheters Product Portfolio

17.2.3 Financial Performance and Market Share

17.2.4 Recent Developments and Strategy

17.2.5 SWOT Analysis

17.3 Fresenius Medical Care

17.3.1 Company Overview

17.3.2 U.S. & Canada Peritoneal Dialysis Catheters Product Portfolio

17.3.3 Financial Performance and Market Share

17.3.4 Recent Developments and Strategy

17.3.5 SWOT Analysis

17.4 Merit Medical Systems

17.4.1 Company Overview

17.4.2 U.S. & Canada Peritoneal Dialysis Catheters Product Portfolio

17.4.3 Financial Performance and Market Share

17.4.4 Recent Developments and Strategy

17.4.5 SWOT Analysis

17.5 Cook Medical

17.5.1 Company Overview

17.5.2 U.S. & Canada Peritoneal Dialysis Catheters Product Portfolio

17.5.3 Financial Performance and Market Share

17.5.4 Recent Developments and Strategy

17.5.5 SWOT Analysis

17.6 B. Braun

17.6.1 Company Overview

17.6.2 U.S. & Canada Peritoneal Dialysis Catheters Product Portfolio

17.6.3 Financial Performance and Market Share

17.6.4 Recent Developments and Strategy

17.6.5 SWOT Analysis

17.7 Teleflex

17.7.1 Company Overview

17.7.2 U.S. & Canada Peritoneal Dialysis Catheters Product Portfolio

17.7.3 Financial Performance and Market Share

17.7.4 Recent Developments and Strategy

17.7.5 SWOT Analysis

17.8 Boston Scientific

17.8.1 Company Overview

17.8.2 U.S. & Canada Peritoneal Dialysis Catheters Product Portfolio

17.8.3 Financial Performance and Market Share

17.8.4 Recent Developments and Strategy

17.8.5 SWOT Analysis

17.9 Cardinal Health

17.9.1 Company Overview

17.9.2 U.S. & Canada Peritoneal Dialysis Catheters Product Portfolio

17.9.3 Financial Performance and Market Share

17.9.4 Recent Developments and Strategy

17.9.5 SWOT Analysis

17.10 AngioDynamics

17.10.1 Company Overview

17.10.2 U.S. & Canada Peritoneal Dialysis Catheters Product Portfolio

17.10.3 Financial Performance and Market Share

17.10.4 Recent Developments and Strategy

17.10.5 SWOT Analysis

18. Strategic Recommendations

18.1 Recommendations for Manufacturers and Suppliers in the U.S. & Canada Peritoneal Dialysis Catheters Market

18.2 Recommendations for Investors

18.3 Recommendations for Buyers and End Users

18.4 Key Success Factors

19. Analyst View & FAQs

19.1 Analyst View on the U.S. & Canada Peritoneal Dialysis Catheters Market

19.2 Research Methodology and Data Validation

19.3 Frequently Asked Questions

19.4 Sources and Abbreviations

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The U.S. & Canada peritoneal dialysis catheters market was valued at USD 168.00 million in 2025 and is estimated at USD 179.42 million in 2026. It is projected to reach USD 324.36 million by 2035.

Answer : The U.S. & Canada peritoneal dialysis catheters market is expected to grow at a CAGR of 6.8% from 2026 to 2035, driven by rising kidney failure, home dialysis incentives, patient preference and new cyclers.

Answer : Swan-Neck Catheters lead the U.S. & Canada peritoneal dialysis catheters market with a 44% share in 2025, because their bent tunnel lowers exit-site infection and migration.

Answer : U.S. dominates the U.S. & Canada peritoneal dialysis catheters market with an 88% share in 2025, while Canada is the fastest-growing country.

Answer : Key players in the U.S. & Canada peritoneal dialysis catheters market include Medtronic, Baxter International (Vantive), Fresenius Medical Care, Merit Medical Systems, Cook Medical, B. Braun, Teleflex, Boston Scientific, Cardinal Health, and other players.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client